NEW XELLIA GROUP A/S
35235299ActiveGlobal leader in fermentation-based anti-infective pharmaceutical manufacturing and supply.
Yleiskatsaus
- 31
- Työntekijät
- Tuntematon
- Liikevaihto
- 2013
- Perustettu
Avainpäättäjät
Steen Riisgaard
Chairman of the Board
Michael Kocher
Chief Executive Officer
Andreas Hylleberg Mølleskov
Director, Communications, Branding and Public Affairs
Regitze Reeh
Vice President Corporate Communications & Public Affairs
+11 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Xellia Pharmaceuticals is a global leader in the development and manufacturing of fermentation-based, non-beta-lactam anti-infective medicines. With a rich legacy spanning over 120 years, the company provides essential Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs) to more...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tuntematon
- Oikeudellinen muoto
- A/S
- ALV-numero
- DK35235299
Päättäjät
15 yhteystietoa FunnelfeedrissäSteen Riisgaard
Chairman of the Board
Michael Kocher
Chief Executive Officer
Andreas Hylleberg Mølleskov
Director, Communications, Branding and Public Affairs
Regitze Reeh
Vice President Corporate Communications & Public Affairs
Julie McHugh
Board Member
Vicente Oller
Chief Financial Officer
Preben Haaning
Board Member
Alexander Sproedt
Chief Operations Officer
Gaël Bernard
Chief Commercial Officer
Søren Hostrup
Chief Legal & Compliance Officer
Florian Falch
Chief People & Culture Officer
Henrik Kjær Hansen
Board Member
Benny D. Loft
Board Member
Muut yhteyshenkilöt
Simone Lorentzen
Senior Communications Specialist
Tamer Medhat
Sales Representative
Samankaltaiset yritykset
20 samankaltaista yritystä FunnelfeedrissäNovo Nordisk Pharmatech A/S
472 työntekijätEnabling life-science innovation through high-quality pharmaceutical ingredients and expertise.
Aspen Nordic, filial af Aspen Pharma Ireland Limited, Irland
8 työntekijätGlobal pharmaceutical company manufacturing and marketing high-quality, affordable medicines.
Croda Denmark A/S
98 työntekijätProviding sustainable, high-performance specialty ingredients for global consumer brands.
CHR. HANSEN A/S
1,654 työntekijätLeading global biosolutions partner transforming industries through innovative biological science.
NIVI Development A/S
7 työntekijätA mission-driven organization translating academic vaccine research into early clinical development.
Selaa lisää
Kysymyksiä yrityksestä NEW XELLIA GROUP A/S
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo